Innovation for the 'Bottom 100 million': Eliminating neglected tropical diseases in the Americas

Advances in Experimental Medicine and Biology

Volumn 764, Issue , 2013, Pages 1-12

  Hotez, Peter J ^a   Dumonteil, Eric ^b   Heffernan, Michael J ^a   Bottazzi, Maria E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AZITHROMYCIN; BENZNIDAZOLE; CLOFAZIMINE; DAPSONE; DENGUE VACCINE; DIETHYLCARBAMAZINE; HOOKWORM VACCINE; IVERMECTIN; LEISHMANIA VACCINE; MEBENDAZOLE; NIFURTIMOX; PARASITE ANTIGEN; PLACEBO; PRAZIQUANTEL; RECOMBINANT VACCINE; RIFAMPICIN; SCHISTOSOMA VACCINE; TRICHOMONIASIS VACCINE; TRYPANOSOMA CRUZI VACCINE; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; ASCARIASIS; CELLULAR IMMUNITY; CENTRAL AMERICA; CHAGAS DISEASE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CYSTICERCOSIS; DENGUE; DRUG CONTRAINDICATION; DRUG COST; DRUG WITHDRAWAL; GOOD MANUFACTURING PRACTICE; HELMINTHIASIS; HUMAN; IMMUNOGENICITY; LEISHMANIASIS; LEPROSY; LYMPHATIC FILARIASIS; MASS IMMUNIZATION; MATERNAL CARE; NECATORIASIS; NEGLECTED DISEASE; NONHUMAN; ONCHOCERCIASIS; PARASITE TRANSMISSION; POVERTY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; PUBLIC-PRIVATE PARTNERSHIP; QUALITY ADJUSTED LIFE YEAR; SCHISTOSOMIASIS; SINGLE DRUG DOSE; SOUTH AMERICA; SPONTANEOUS ABORTION; TOXOCARIASIS; TRACHOMA; TRICHOMONIASIS; TRICHURIASIS; TROPICAL DISEASE; UNSPECIFIED SIDE EFFECT; VACCINE PRODUCTION; VECTOR CONTROL;

EID: 84873585444     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4726-9_1     Document Type: Article

References (66)

1. http://data.worldbank.org/topic/poverty. Accessed 3 Sept 2011
2. http://www.ruralpovertyportal.org/web/guest/region/home/tags/americas. Accessed 3 Sept 2011
3. http://www.eoearth.org/article/Human-Development-Index-for-Latin-America- Caribbean-Nations. Accessed 3 Sept 2011
4. http://www.census.gov/newsroom/releases/archives/income-wealth/cb11-157. html. Accessed 13 Sept 2011
5. Hotez PJ (2008) Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis 2:e2566
6. Hotez PJ (2011) America's most distressed areas and their neglected infections: The United States Gulf Coast and the District of Columbia. PLoS Negl Trop Dis 5:e8433
7. Hotez PJ (2010) Neglected infections of poverty among the indigenous peoples of the Arctic. PLoS Negl Trop Dis 4:e6066
8. http://www.worldhunger.org/articles/Learn/world%20hunger%20facts%202002. htm. Accessed 3 Sept 2011
9. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault S, Periago MR (2008) The neglected tropical diseases of Latin America and the Caribbean: A review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2:e3000
10. Hotez PJ, Fenwick A, Kumaresan J, Molyneux DH, Ehrlich Sachs S, Sachs JD, Savioli L (2007) Control of neglected tropical diseases. N Engl J Med 357:1018-10277
11. Hotez PJ, Fenwick A, Savioli L, Molyneux DH (2009) Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373:157-1555
12. World Health Organization (2010) Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases. Geneva. http://www.who.int/neglected-diseases/2010report/en/index.html. p 1722
13. Hotez PJ, Ferris M (2006) The anti-poverty vaccines. Vaccine 24:5787-57999
14. Furtado JM, Smith JR, Belfort R, Gattey D, Winthrop KL (2011) Toxoplasmosis: A global threat. J Global Infect Dis 3:281-2844
15. Lammie PJ, Lindo JF, Secor WE, Vasquez J, Ault SK et al (2007) Eliminating lymphatic filariasis, onchocerciasis and schistosomiasis from the Americas: Breaking a historical legacy of slavery. PLoS Negl Trop Dis 1:e711
16. Tapia-Conyer R, Mendez-Galvan JF, Gallardo-Rincon H (2009) The growing burden of dengue in Latin America. J Clin Virol 46(Suppl 2):S3-66
17. Hotez PJ (2008) The giant anteater in the room: Brazil's neglected tropical diseases problem. PLoS Negl Trop Dis 2:e1777
18. Hotez PJ, Brooker S, Bethony JM, Bottazzi ME, Loukas A, Xiao SH (2004) Hookworm infection. N Engl J Med 351:799-8077
19. Smith JL, Brooker S (2010) Impact of hookworm infection and deworming on anemia in non-pregnant populations: A systematic review. Trop Med Int Health 15:776-7955
20. Brooker S, Hotez PJ, Bundy DAP (2008) Hookworm-related anaemia among pregnant women: A systematic review. PLoS Negl Trop Dis 2:e2911
21. Brooker S, Jardim-Botelho A, Quinnell RJ, Geiger SM, Caldas IR, Fleming F, Hotez PJ, Correa-Oliveira R, Rodrigues LC, Bethony JM (2007) Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil. Trans R Soc Trop Med Hyg 101:146-1544
22. Larocque R, Casapia M, Gotuzzo E, MacLean JD, Soto JC et al (2006) A double-blind randomized controlled trial of antenatal mebendazole to educe low birthweight in a hookworm-endemic area of Peru. Trop Med Int Health 11:1485-14955
23. Theiler RN, Rasmussen SA, Treadwell TA, Jamieson DJ (2008) Emerging and zoonotic infections in women. Infect Dis Clin North Am 22:755-7722
24. Siriano L da R, Luguetti AO, Avelar JB, Marra NL, de Castro AM (2011) Chagas disease: Increased parasitemia during pregnancy detected by hemoculture. Am J Trop Med Hyg 84:569-5744
25. Perez-Lopez FR, Chedraui P (2010) Chagas disease in pregnancy: A non-endemic problem in a globalized world. Arch Gynecol Obstet 282:595-5999
26. Buekens P, Almendares O, Carlier Y, Dumonteil E, Eberhard M, Gamboa-Leon R, James M, Padilla N, Wesson D, Xiong X (2008) Mother-to-child transmission of Chagas disease in North America: Why don't we do more? Matern Child Health J 12:283-2866
27. Giraldo D, Sant'anna C, Perisse AR, March MD, Souza AP, Mendes A, Bonfim M, Hofer CB (2011) Characteristics of children hospitalized with dengue fever in an outbreak in Rio de Janeiro, Brazil. Trans R Soc Trop Med Hyg 105(10):601-603 (Epub 2011 Aug 19) \\
28. Rodriguez-Barraquer I, Cordeiro MT, Braga C, de Souza WV, Marques ET, Cummings DA (2011) From re-emergence to hyperendemicity: The natural history of the dengue epidemic in Brazil. PLoS Negl Trop Dis 5:e9355
29. Pouliot SH, Xiong X, Harville E, Paz-Soldan V, Tomashek KM, Breart G, Buekens P (2010) Maternal dengue and pregnancy outcomes: A systematic review. Obstet Gynecol Surg 65:107-1188
30. Bleakley H (2007) Disease and development: Evidence from hookworm eradication in the American South. Q J Econ 122:73-1177
31. Lee BY, Bacon KM, Connor DL, Willig AM, Bailey RR (2010) The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America. PLoS Negl Trop Dis 4(12):e9166
32. Garg P, Nagpal J, Khairnar P, Seneviratne SL (2008) Economic burden of dengue infections in India. Trans R Soc Trop Med Hyg 102:570-5777
33. Beatty ME, Beutels P, Meltzer MI, Shepard DS, Hombach J, Hutubessy R, Dessis D, Coudeveille L, Dervaux B, Wichmann O, Margolis HS, Kuritsky JN (2011) Health economics of dengue: A systematic literature review and expert panel's assessment. Am J Trop Med 84:473-4888
34. Hotez PJ, Thompson TG (2009) Waging peace through neglected tropical disease control: A US foreign policy for the bottom billion. PLoS Negl Trop Dis 3:e3466
35. Beyrer C, Villar JC, Suwanvanichkij V, Singh S, Baral SD et al (2007) Neglected diseases, civil conflicts, and the right to health. Lancet 370:619-6277
36. Hotez PJ (2009) Mass drug administration and the integrated control of the world's high prevalence neglected tropical diseases. Clin Pharamcol Therap 85:659-6644
37. Schneider MC, Aguilera XP, Barbosa da Silva Jr J, Ault SK, Najera P, Martinez J, Requejo R, Nicholls RS, Yadon Z, Silva JC, Leanes LF, Periago MR (2011) Elimination of neglected diseases in Latin America and the Caribbean: A mapping of selected diseases. PLoS Negl Trop Dis 5:e9644
38. Hotez P (2011) Enlarging the "audacious goal": Elimination of the world's high prevalence neglected tropical diseases. Vaccine (in press) \\
39. Bitran R, Martorell B, Escobar L, Munoz R, Glassman A (2009) Controlling and eliminating neglected diseases in Latin America and the Caribbean. Health Aff (Millwood) 28:1707-17199
40. World Health Organization (2011) Leprosy update, 2011. World Epidemiol Rec 36:389-4000
41. Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Diemert D, Loukas A (2006) New technologies for the control of human hookworm infection. Trends Parasitol 22:327-3311
42. Reithinger R, Tarleton R, Urbina JA, Kitron U, Gurtler RE (2009) Eliminating Chagas disease: Challenges and a roadmap. BMJ 338:b12833
43. Hotez P (2011) A handful of 'anti-poverty' vaccines exist for neglected diseases, but the world's poorest billion people need more. Health Aff 30:1080-10877
44. Coller BA, Clements DE (2011) Dengue vaccines: Progress and challenges. Curr Opin Immunol 23:391-3988
45. Hotez PJ, Bethony JM, Diemert DJ, Pearson M, Loukas A (2010) Developing vaccines to combat hookworminfection and intestinal schistosomiasis. Nat Rev Microbiol 8:814-8266
46. Lee BY, Bacon KM, Bailey R, Wiringa AE, Smith KJ (2011) The potential economic value of a hookworm vaccine. Vaccine 29:1201-12100
47. Quijano-Hernandez I, Dumonteil E (2011) Advances and challenges towards a vaccine against Chagas disease. Hum Vaccin (in press)\\
48. Rassi Jr. A, Rassi A, Marin-Neto JA (2010) Chagas disease. Lancet 375:1388-14022
49. Perez-Molina JA, Perez-Ayala A, Moreno S, Fernandez-Gonzalez MC, Zamora J, Lopez-Velez R (2009) Use of benznidazole to treat chronic Chagas' disease: A systematic review with a meta-analysis. J Antimicrob Chemother 64:1139-11477
50. Sarli Issa V, Alcides Bocchi E (2010) Antitrypanosomal agents: Treatment or threat? Lancet 376:768-7699
51. Marin-Neto JA, Rassi A Jr, Morillo CA et al on behalf of BENEFIT Investigators (2008). Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas cardiomyopathy: The BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT). Am Heart J 156:37-433
52. Pinazo M-J, Munoz J, Posada E, Lopez-Chejade P, Gallego M, Ayala E, del Cacho E, Soy D, Gascon J (2010) Tolerance of benznidazole in treatment of Chagas' disease in Adults. Antmicrob Agents Chemother 54:4896-48999
53. Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Armenti A (2009) Side effects of benznidazole as treatment in chronic Chagas disease: Fears and realities. Expert Rev AntiInfect Therap 7:157-1633
54. Castillo-Riqueime M, Guhl F, Turriago B, Pinto N, Rosas F, Florez Moartinez M, Fox-Rushby J, Davies C, Campbell-Lendrum D (2008) The costs of preventing and treating Chagas disease in Colombia. PLoS Negl Trop Dis 2(11):e3366
55. Dumonteil E, Escobedo-Ortegon J, Reyes-Rodriguez N, Arjona-Torres A, Ramirez-Sierra J (2004) Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice. Infect Immun 72(1):46-533
56. Zapata-Estrella H, Hummel-Newell C, Sanchez-Burgos G, Escobedo-Ortegon J, Ramirez-Sierra MJ, Arjona-Torres A, Dumonteil E (2006) Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice. Immunol Lett 103:186-1911
57. Sanchez-Burgos G, Mezquite-Vega RG, Escobedo-Ortegon J et al (2007) Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice. FEMS Immunol Med Microbiol 50:333-3411
58. Limon-Flores AY, Cervera-Cetina R, Tzec-Arjona JL et al (2010) Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: Role of CD4+ and CD8+ cells. Vaccine 28(46):7414-74199
59. O'Hagan DT, De Gregorio E (2009) The path to a successful vaccine adjuvant - 'the long and winding road'. Drug Discov Today 14:541-5511
60. Oyewumi MO, Kumar A, Cui Z (2010) Nano-microparticles as immune adjuvants: Correlating particle sizes adn the resultant immune responses. Expert Rev Vaccines 9:1095-11077
61. Heffernan MJ, Kasturi SP, Yang SC, Pulendran B, Murthy N (2009) The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid). Biomaterials 30:910-9188
62. Heffernan MJ, Zaharoff DA, Fallon JK, Schlom J, Greiner JW (2011) In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines. Biomaterials 32:926-9322
63. Roller CS, Reyes-Sandoval A, Cottingham MG, Ewer K, Hill AVS (2011) Viral vectors as vaccine platform: Deployment in sight. Curr Opin Immunol 23:377-3822
64. Cavenaugh JS, Awi D, Mendy M, Hill AVS, Whittle H, McConkey S (2011) Partially randomized, nonblinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection. PLoS One 6:e146266
65. Hill AVS, Reyes-Sandoval A, O'Hara G, Ewer K, Lawrie Al, Goodman A, Nicosia A, Folgori A, Colloca S, Coretese R, Gilbert SC, Draper SJ (2010) Prime-boost vectored malaria vaccines. Hum Vaccin 6:78-833
66. Lee BY, Bacon KM, Connor DL, Willig AM, Bailey RR (2010) The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America. PLoS Negl Trop Dis 4(12):e916.